Cargando…

Value of SUV(max) for the Prediction of Bone Invasion in Oral Squamous Cell Carcinoma

In advanced oral squamous cell carcinoma (OSCC), accurate planning of surgical resection and reconstruction are crucial for outcome and postoperative function. For OSCC close to the maxilla or mandible, prediction of bone invasion is necessary. The aim of this study was to examine whether metabolic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stalder, Stephanie A., Schumann, Paul, Lanzer, Martin, Hüllner, Martin W., Rupp, Niels J., Broglie, Martina A., Morand, Grégoire B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167854/ https://www.ncbi.nlm.nih.gov/pubmed/32024247 http://dx.doi.org/10.3390/biology9020023

Ejemplares similares

Correction: Stalder, et al.; Value of SUV(max) for the Prediction of Bone Invasion in Oral Squamous Cell Carcinoma. Biology 2020, 9, 23
por: Stalder, Stephanie A., et al.
Publicado: (2020)

Predictive Value of Pretherapeutic Maximum Standardized Uptake Value (Suv(max)) In Laryngeal and Hypopharyngeal Cancer
por: Werner, Jonas, et al.
Publicado: (2019)

Predictive value of suvmax changes between two sequential post-therapeutic FDG-pet in head and neck squamous cell carcinomas
por: Stadler, Thomas M., et al.
Publicado: (2020)

Maximum Standardized Uptake Value (SUV(max)) of Primary Tumor Predicts Occult Neck Metastasis in Oral Cancer
por: Morand, Grégoire B., et al.
Publicado: (2018)

Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype
por: Morand, Grégoire B., et al.
Publicado: (2020)

Histopathological Analysis of Nodal Disease After Chemoradiation Reveals Viable Tumor Cells as the most Important Prognostic Factor in Head and Neck Squamous Cell Carcinoma
por: Golliez, Aline, et al.
Publicado: (2023)

Need for adjuvant radiotherapy in oral cancer: depth of invasion rather than tumor diameter
por: Riemenschnitter, Cosima E., et al.
Publicado: (2022)

Pretreatment SUV(max) value to predict outcome in patients with stage III NSCLC receiving concurrent chemoradiotherapy
por: Yaprak, Gokhan, et al.
Publicado: (2019)

FDG PET using SUV(max) for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy
por: Huang, Yung-Cheng, et al.
Publicado: (2017)

Expanding the clinicopathological spectrum of TGFBR3‐PLAG1 rearranged salivary gland neoplasms with myoepithelial differentiation including evidence of high‐grade transformation
por: Rupp, Niels J., et al.
Publicado: (2021)

Who’s Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal Melanoma
por: Freiberger, Sandra N., et al.
Publicado: (2021)

Significance of SUV Max for Predicting Occult Lymph Node Metastasis and Prognosis in Early-Stage Tongue Squamous Cell Carcinoma
por: Xu, Chunmiao, et al.
Publicado: (2020)

Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients
por: Freiberger, Sandra N., et al.
Publicado: (2022)

SalvGlandDx – a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets
por: Freiberger, Sandra N., et al.
Publicado: (2021)

Correlation of (18)F-FDG/PET SUV(max), SUV(mean), MTV, and TLG with HIF-1α in Patients with Colorectal Cancer
por: Kaymak, Zümrüt Arda, et al.
Publicado: (2021)

Morpho-Molecular Assessment Indicates New Prognostic Aspects and Personalized Therapeutic Options in Sinonasal Melanoma
por: Freiberger, Sandra N., et al.
Publicado: (2019)

Utility of SUV(max) on (18) F-FDG PET in detecting cervical nodal metastases
por: Lim, Rebecca S. M., et al.
Publicado: (2016)

Prognostic value of SUV(max) in breast cancer and comparative analyses of molecular subtypes: A systematic review and meta-analysis
por: Lee, Moon il, et al.
Publicado: (2021)

Assessment of Mediastinal Tumors Using SUV(max) and Volumetric Parameters on FDG-PET/CT
por: Morita, Takahiro, et al.
Publicado: (2017)

Histopathological Analysis of Nodal Disease After Chemoradiation Reveals Viable Tumor Cells as the most Important Prognostic Factor in Head and Neck Squamous Cell Carcinoma, DOI 10.1007/s12105-023-01557-7
por: Morand, Grégoire B., et al.
Publicado: (2023)

Early Changes of the Standardized Uptake Values (SUV(max)) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer
por: Sirico, Marianna, et al.
Publicado: (2020)

Prognostic value of nodal SUV(max) of (18)F-FDG PET/CT in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Lee, So Jung, et al.
Publicado: (2017)

A dataset on patient-individual lymph node involvement in oropharyngeal squamous cell carcinoma
por: Ludwig, Roman, et al.
Publicado: (2022)

Frequency and Localization of Second Primary Tumors in Patients with Oropharyngeal Carcinoma—The Influence of the Human Papilloma Virus
por: Bosshart, Salome L., et al.
Publicado: (2021)

Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

High Basal Maximal Standardized Uptake Value (SUV(max)) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2021)

Deformation Effect on SUV(max) Changes in Thoracic Tumors Using 4-D PET/CT Scan
por: Huang, Tzung-Chi, et al.
Publicado: (2013)

Prognostic Prediction of BRCA Mutations by (18)F-FDG PET/CT SUV(max) in Breast Cancer
por: Özdemir, Semra, et al.
Publicado: (2021)

Congenital fistula of the fourth branchial arch: Report of case with long‐lasting misdiagnosis
por: Stadler, Thomas M., et al.
Publicado: (2019)

SUV(fdg): A standard-uptake-value (SUV) body habitus normalizer specific to fluorodeoxyglucose (FDG) in humans
por: Beattie, Bradley J., et al.
Publicado: (2022)

The Impact of Primary Tumor and Locoregional Metastatic Lymph Node SUV(max) on Predicting Survival in Patients with Rectal Cancer
por: Alçın, Göksel, et al.
Publicado: (2020)

Day 30 SUV(max) predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy
por: Al Zaki, Ajlan, et al.
Publicado: (2022)

Comparison of SUV(max) Values Obtained from F-18 FDG PET/CT and Cell-free DNA Levels Measured from Plasma in Oncology Patients
por: Çelik, Fatmanur, et al.
Publicado: (2019)

Overall Neutrophil-to-Lymphocyte Ratio and SUV(max) of Nodal Metastases Predict Outcome in Head and Neck Cancer Before Chemoradiation
por: Werner, Jonas, et al.
Publicado: (2021)

SUV(max) reduction predicts long-term survival in patients of non-pCR both in the tumor and lymph nodes after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
por: Nagaki, Yushi, et al.
Publicado: (2021)

Radioactive nanosized colloids and indocyanine green identify the same sentinel lymph nodes in oral squamous cell carcinoma
por: Hingsammer, Lukas, et al.
Publicado: (2023)

Is it safe to drive SUVs?
Publicado: (1998)

Clinical impact of SUV(max) of interstitial lesions in lung cancer patients with interstitial lung disease who underwent pulmonary resection
por: Akaike, Kimitaka, et al.
Publicado: (2022)

Pretreatment SUV(max) predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
por: Horne, Zachary D, et al.
Publicado: (2014)

Value of FDG-PET/MR in Oral Focus Assessment in Head and Neck Cancer Patients—A Feasibility Study
por: Valdec, Silvio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fpuh1n181nrihepo1cim0v6dtf